trending Market Intelligence /marketintelligence/en/news-insights/trending/jyxrf6kf_6v4orgh6tg1pq2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Kadmon closes common stock offerings

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Kadmon closes common stock offerings

Kadmon Holdings Inc. closed its previously announced offerings to raise about $113.2 million.

The total proceeds include funds raised due to underwriters fully exercising their option to buy additional shares.

The New York-based biopharmaceutical company plans to use the proceeds for preclinical and clinical development of its lead product candidates, as well as other general corporate purposes among others.

Jefferies LLC acted as sole book-running manager for the underwritten offering, with H.C. Wainwright & Co. LLC as lead manager.